Submit Deal

CONCENTRA BIOSCIENCES

HQ - San Diego

Summary

Concentra Biosciences was formed under the laws of the State of Delaware on March 8, 2023 and a biotechnology investment and development company.

Deals Overview

Total Deals7

Valued Deals7

Total Value£ 615 M

Avg. Deal Size£ 88 M

Market Context

Senior Management

Kevin Tang
CEO
Keith Newton
President and CEO
Matt DiCanio
President and CFO

Sort

22 Dec 2023|United States|Biotechnology

Target: THESEUS PHARMACEUTICALS

Bidder: CONCENTRA BIOSCIENCES

4 Service Providers

3 Target | 1 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 148 M

Value

02 Apr 2025|United States|Biotechnology

Target: ALLAKOS INC

Bidder: CONCENTRA BIOSCIENCES

5 Service Providers

3 Target | 2 Bidder

5 Dealmakers

2 Target | 3 Bidder

£ 26 M

Value

01 May 2025|United States|Pharmaceuticals

Target: KRONOS BIO

Bidder: CONCENTRA BIOSCIENCES

6 Service Providers

4 Target | 2 Bidder

17 Dealmakers

14 Target | 3 Bidder

£ 26 M

Value

09 Jun 2025|United States|Biotechnology

Target: ELEVATION ONCOLOGY

Bidder: CONCENTRA BIOSCIENCES

4 Service Providers

2 Target | 2 Bidder

15 Dealmakers

12 Target | 4 Bidder

£ 19 M

Value

01 Jul 2025|United States|Biotechnology

Target: IGM BIOSCIENCES

Bidder: CONCENTRA BIOSCIENCES

6 Service Providers

4 Target | 2 Bidder

5 Dealmakers

2 Target | 3 Bidder

£ 59 M

Value

08 Jul 2025|United States|Biotechnology

Target: CARGO THERAPEUTICS

Bidder: CONCENTRA BIOSCIENCES

7 Service Providers

5 Target | 2 Bidder

27 Dealmakers

25 Target | 2 Bidder

£ 159 M

Value

21 Jul 2025|United States|Biotechnology

Target: ITEOS THERAPEUTICS SA

Bidder: CONCENTRA BIOSCIENCES

6 Service Providers

4 Target | 2 Bidder

11 Dealmakers

8 Target | 3 Bidder

£ 176 M

Value